Fenebrutinib free base
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 206475

CAS#: 1434048-34-6 (free base)

Description: Fenebrutinib, also known as GDC-0853, is orally available inhibitor of Bruton's tyrosine kinase (BTK) with potential antineoplastic activity. Upon administration, GDC-0853 inhibits the activity of BTK and prevents the activation of the B-cell antigen receptor (BCR) signaling pathway. This prevents both B-cell activation and BTK-mediated activation of downstream survival pathways, which leads to the inhibition of the growth of malignant B-cells that overexpress BTK. BTK, a member of the Src-related BTK/Tec family of cytoplasmic tyrosine kinases, is overexpressed in B-cell malignancies; it plays an important role in B-lymphocyte development, activation, signaling, proliferation and survival.


Price and Availability

Size
Price

10mg
USD 150
100mg
USD 850
1g
USD 4650
Size
Price

25mg
USD 250
200mg
USD 1450
2g
USD 7950
Size
Price

50mg
USD 450
500mg
USD 2950

Fenebrutinib (GDC-0853), purity > 98%, is in stock. The same day shipping out after order is received. Note: grams are in stock now, and available for the same day shipping out.


Chemical Structure

img

Theoretical Analysis

MedKoo Cat#: 206475
Name: Fenebrutinib free base
CAS#: 1434048-34-6 (free base)
Chemical Formula: C37H44N8O4
Exact Mass: 664.3486
Molecular Weight: 664.811
Elemental Analysis: C, 66.85; H, 6.67; N, 16.86; O, 9.63


Related CAS #: 1434048-34-6 (free base)   2128304-54-9 (HCl)   2128304-53-8 (mesylate)   2128304-55-0 (sulfate)    

Synonym: GDC-0853; GDC 0853; GDC0853; RG-7845; RG7845; RG 7845; Fenebrutinib; Fenebrutinib free base;

IUPAC/Chemical Name: (S)-2-(3'-(hydroxymethyl)-1-methyl-5-((5-(2-methyl-4-(oxetan-3-yl)piperazin-1-yl)pyridin-2-yl)amino)-6-oxo-1,6-dihydro-[3,4'-bipyridin]-2'-yl)-7,7-dimethyl-3,4,7,8-tetrahydro-2H-cyclopenta[4,5]pyrrolo[1,2-a]pyrazin-1(6H)-one

InChi Key: WNEODWDFDXWOLU-QHCPKHFHSA-N

InChi Code: InChI=1S/C37H44N8O4/c1-23-18-42(27-21-49-22-27)9-10-43(23)26-5-6-33(39-17-26)40-30-13-25(19-41(4)35(30)47)28-7-8-38-34(29(28)20-46)45-12-11-44-31(36(45)48)14-24-15-37(2,3)16-32(24)44/h5-8,13-14,17,19,23,27,46H,9-12,15-16,18,20-22H2,1-4H3,(H,39,40)/t23-/m0/s1

SMILES Code: O=C1C(N2CCN1C3=NC=CC(C(C=C4NC5=NC=C(N6[C@@H](C)CN(C7COC7)CC6)C=C5)=CN(C)C4=O)=C3CO)=CC8=C2CC(C)(C)C8


Technical Data

Appearance:
White to off-white solid powder

Purity:
>98% (or refer to the Certificate of Analysis)

Certificate of Analysis:

Safety Data Sheet (MSDS):

Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition:
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility:
Soluble in DMSO, not in water

Shelf Life:
>2 years if stored properly

Drug Formulation:
This drug may be formulated in DMSO

Stock Solution Storage:
0 - 4 C for short term (days to weeks), or -20 C for long term (months).

Harmonized System Code:
2934990300


Additional Information

Note: Structure was from https://newdrugapprovals.org/2016/03/ ( visited on 4/7/2016)


References

Heteroarylpyridone and azapyridone compounds as inhibitors of BTK activity and their preparation
By Crawford, James John; Ortwine, Daniel Fred; Wei, Binqing; Young, Wendy B.
From PCT Int. Appl. (2013), WO 2013067274 A1 20130510.